Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive‐Compulsive Disorder
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2025
DOI: 10.1002/ajmg.b.33026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2025. Verfasst von Julia Bäckman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stoc…. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Cognitive Behavioral Therapy, Multifactorial Inheritance. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX), Swedish Research Council, Clinical Therapy Research in the Specialist Health Services.
Abstract (Originalsprache)
A large proportion of patients undergoing cognitive behavior therapy (CBT) for obsessive‐compulsive disorder (OCD) do not respond sufficiently to treatment. Identifying predictors for change in symptom severity after treatment could inform clinical decision‐making, allow for better‐tailored interventions, and avoid treatment failure. Prior research on predictors for treatment response has, however, yielded inconsistent findings with limited clinical utility. Here, we investigated the predictive power of nine polygenic risk scores (PRSs) for psychiatric and cognitive traits in 1598 OCD patients (1167 adults and 431 children/adolescents) treated with CBT in Sweden and Norway. We fitted linear mixed models adjusted for age, sex, genotyping batch, and the first five ancestry PCs to estimate associations between PRS and symptom severity change from pre‐ to post‐treatment. The PRS for schizophrenia showed a modestly significant association with symptom change ( β = 0.013, p = 0.04, R 2 = 0.10), indicating that a higher PRS for schizophrenia was associated with a smaller decrease in symptom severity. No other PRS were significantly associated with the outcome. While these results await replication and expansion, current PRS for psychiatric and cognitive phenotypes do not seem to contribute meaningfully to symptom severity change in CBT for OCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Julia Bäckman, Matthew Halvorsen, James J Crowley
Förderung
- Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)
- Swedish Research Council
- Clinical Therapy Research in the Specialist Health Services
- Centre for Innovative Medicine
- NIMH NIH HHS
- The Söderström-Königska Foundation
- NIH HHS
- Trond Mohn Foundation
Zitieren
APA
Bäckman, J., Wallert, J., Halvorsen, M., Roelstraete, B., de Schipper, E., Strom, N. I., Eide, T. O., Höffler, K. D., Mattheisen, M., Hansen, B., Kvale, G., Hagen, K., Haavik, J., Nordic OCD and Related Disorders Consortium (NORDiC), Mataix-Cols, D., Rück, C., & Crowley, J. J. (2025). Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive‐Compulsive Disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.33026
Vancouver
Bäckman J, Wallert J, Halvorsen M, Roelstraete B, de Schipper E, Strom NI, et al. Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive‐Compulsive Disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2025. doi:10.1002/ajmg.b.33026
BibTeX
@article{Bckman2025,
author = {Bäckman, Julia and Wallert, John and Halvorsen, Matthew and Roelstraete, Bjorn and de Schipper, Elles and Strom, Nora I and Eide, Thorstein Olsen and Höffler, Kira D and Mattheisen, Manuel and Hansen, Bjarne and Kvale, Gerd and Hagen, Kristen and Haavik, Jan and Nordic OCD and Related Disorders Consortium (NORDiC), Nordic OCD and Related Disorders Consortium (NORDiC) and Mataix-Cols, David and Rück, Christian and Crowley, James J},
title = {Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive‐Compulsive Disorder},
journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
year = {2025},
doi = {10.1002/ajmg.b.33026}
}
EUVIMED